{"transactions":[{"id":1120951,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-05T20:06:29.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting upon one year from date of grant."}],"balance_after":11526,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013793/ownership.xml","form_type":"4"}},{"id":1486204,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-07T21:39:17.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"balance_after":10938,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023207/ownership.xml","form_type":"4"}},{"id":1894730,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2023-05-12T20:33:49.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"balance_after":166000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016684/ownership.xml","form_type":"4"}},{"id":2235476,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2022-06-10T15:33:32.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"balance_after":136000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016401/ownership.xml","form_type":"4"}},{"id":2673442,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T18:42:45.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":22000,"price":1.26,"value":27720.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":1.26,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-21-000537","document":"doc4_7259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000537/doc4_7259.xml","form_type":"4"}},{"id":2939425,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:07:06.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":5625,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001638599-20-000979","document":"doc4_6962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000979/doc4_6962.xml","form_type":"4"}},{"id":2939424,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T21:07:06.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":6562,"source":{"system":"sec-edgar","filing":"0001638599-20-000979","document":"doc4_6962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000979/doc4_6962.xml","form_type":"4"}},{"id":3114377,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T20:11:11.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000592","document":"doc4_6752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000592/doc4_6752.xml","form_type":"4"}},{"id":3489129,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T15:10:34.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":10000,"price":1.68,"value":16800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":10000,"derivative":{"exercise_price":1.68,"exercise_date":"2020-06-12","expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-19-000608","document":"doc4_6154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000608/doc4_6154.xml","form_type":"4"}},{"id":3881187,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-28T16:29:32.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":20000,"price":1.33,"value":26600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":20000,"derivative":{"exercise_price":1.33,"exercise_date":"2019-06-27","expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001638599-18-000700","document":"doc4_5502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000700/doc4_5502.xml","form_type":"4"}},{"id":4116816,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-01-02T23:14:52.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":5625,"derivative":{"exercise_price":0,"exercise_date":"2017-12-29","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001638599-18-000024","document":"doc4_5175.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000024/doc4_5175.xml","form_type":"4"}},{"id":4116815,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-01-02T23:14:52.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":938,"price":3.4737,"value":3258.3306,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54."}],"balance_after":937,"source":{"system":"sec-edgar","filing":"0001638599-18-000024","document":"doc4_5175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000024/doc4_5175.xml","form_type":"4"}},{"id":4116814,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-02T23:14:52.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001638599-18-000024","document":"doc4_5175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000024/doc4_5175.xml","form_type":"4"}},{"id":4477009,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":78831,"kind":"person","name":"Fink Jeffrey Arvin","position":1,"cik":"0001595930","reported_name":"Fink Jeffrey Arvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-01-31T02:40:22.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":7500,"derivative":{"exercise_price":0,"exercise_date":"2017-12-31","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001638599-17-000127","document":"doc4_4500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859917000127/doc4_4500.xml","form_type":"4"}}]}